Publication Name	World Journal of Clinical Oncology
Manuscript ID	30730
Country	United States

Received	2016-10-14 08:54
Peer-Review Started	2016-10-15 22:50
To Make the First Decision	2016-12-14 08:43
Return for Revision	2016-12-15 11:29
Revised	2016-12-29 16:50
Second Decision	2017-02-08 15:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-02-20 15:00
Articles in Press	2017-02-20 15:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-03-30 14:43
Publish the Manuscript Online	2017-04-07 08:24

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	How best to manage gastrointestinal stromal tumor
Manuscript Source	Invited Manuscript
All Author List	Gandhi Lanke and Jeffrey H Lee
Funding Agency and Grant Number
Corresponding Author	Jeffrey H Lee, MD, MPH, FASGE, FACG, AGAF, President-Elect (Texas Society for Gastroenterology and Endoscopy), Professor (Department of Gastroenterology, Hepatology, and Nutrition), Director (Advanced Therapeutic Endoscopy Fellowship), Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States. jefflee@mdanderson.org
Key Words	Gastrointestinal stromal tumor; Endoscopy; Endoscopic ultrasound-fine-needle aspiration; Tyrosine kinase inhibitor; Imatinib
Core Tip	Gastrointestinal stromal tumors (GISTs) are most common mesenchymal tumors in the gastrointestinal tract. The management of GISTs is revolutionized with the advent of tyrosine kinase inhibitors (TKIs) and newer advanced endoscopic techniques. Accurate identification and differentiation of GISTs from other submucosal tumors is achieved with the help of endoscopic ultrasound. The management of small to medium GISTs are feasible by newer advanced endoscopic and/or laparoscopic techniques. Team approach involving endoscopist, pathologist, radiologist, medical oncologist and surgeon is key in optimal management of GISTs. This article focuses on role of TKIs and endoscopist perspective in the management of GISTs.
Publish Date	2017-04-07 08:24
Citation	Lanke G, Lee JH. How best to manage gastrointestinal stromal tumor. World J Clin Oncol 2017; 8(2): 135-144
URL	http://www.wjgnet.com/2218-4333/full/v8/i2/135.htm
DOI	http://dx.doi.org/10.5306/wjco.v8.i2.135

Full Article (PDF)	WJCO-8-135.pdf
Full Article (Word)	WJCO-8-135.doc
Manuscript File	30730-Review.docx
Answering Reviewers	30730-Answering reviewers.pdf
Audio Core Tip	30730-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	30730-Conflict-of-interest statement.pdf
Copyright License Agreement	30730-Copyright assignment.pdf
Peer-review Report	30730-Peer-review(s).pdf
Scientific Misconduct Check	30730-Scientific misconduct check.pdf
Scientific Editor Work List	30730-Scientific editor work list.pdf